How much is the Global Stem Cell Therapy Market worth?

Global Stem Cell Therapy Market market size is Expected to Reach USD 44.5 Bn by 2032.

What was the Market Segmentation of the Stem Cell Therapy Market?

By Cell Source (IPSCS, PPSCS, Neural, Embryo/Cord, Adipose Tissue, And Bone Marrow); By Type (Allogenic And Autologous); By Application (Cardiovascular, Diabetes, Cancer, Musculoskeletal Disorders, And Gastrointestinal Diseases); By End User (Hospitals & Clinics, Academic & Research Centers, Ambulatory Surgical Centers, And Other End Users)

What is the CAGR of Stem Cell Therapy Market?

The Stem Cell Therapy Marketis growing at a CAGR of 15.3% during the forecast period 2023 to 2033.

Who are the major players operating in the Stem Cell Therapy Market?

Seraxis, Inc. (Germany), Fresenius Medical Care AG & Co. KGaA (Germany), Generex Biotechnology (Canada), Medipost Co., Ltd (South Korea), Pharmicell Co., Ltd (South Korea), JCR Pharmaceuticals Co.,(Japan), Novadip Biosciences(Belgium), Anterogen Co., Ltd (South Korea), StemCell Technologies Inc. (Canada), Sernava Corp (Canada), NextCell Pharma AB (US), ViaCyte, Inc. (US), Vertex Pharmaceuticals (US), NuVasive, Inc. (US), Novo Nordisk A/S (Denmark),Kadimastem (Israel), Betalin Therapeutics Ltd (Israel), and Other Key Players

Which region will lead the Global Stem Cell Therapy Market?

North America is estimated to be the fastest-growing region during the forthcoming years.

Global Stem Cell Therapy Market By Cell Source (Ipscs, Ppscs, Neural), By Type (Allogenic And Autologous), By Application (Cardiovascular, Diabetes), By End User (Hospitals & Clinics, Academic & Research Centers) By Region And Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends, And Forecast; 2023-2032

Published date: Nov 2023
Report ID: 12272
Number of Pages: 329
Format:

- Seraxis, Inc. (Germany)
- Fresenius Medical Care AG & Co. KGaA (Germany)
- Generex Biotechnology (Canada)
- Medipost Co., Ltd (South Korea)
- Pharmicell Co., Ltd (South Korea)
- JCR Pharmaceuticals Co., (Japan)
- Novadip Biosciences(Belgium)
- Anterogen Co., Ltd (South Korea)
- StemCell Technologies Inc. (Canada)
- Sernava Corp (Canada)
- NextCell Pharma AB (US)
- ViaCyte, Inc. (US)
- Vertex Pharmaceuticals (US)
- NuVasive, Inc. (US)
- Novo Nordisk A/S (Denmark)
- Kadimastem (Israel)
- Betalin Therapeutics Ltd (Israel)
- Other Key Players

Related Reports

Our Clients

Report ID 12272
Published Date Nov 2023
Rating
- ★★★★★
  
  ★★★★★
- (45)

Buy Now

Trusted by more than 17382 organizations globally

✖

Request a Sample Report

We'll get back to you as quickly as possible